A new “ON-OFF” fluorescent and colorimetric chemosensor based on 1,3,4-oxadiazole derivative for the detection of Cu2+ ions
-
Add time:07/14/2019 Source:sciencedirect.com
A symmetrical oxadiazole derivative (OXD) containing two pyrazole moieties was synthesized successfully and characterized by single crystal X-ray diffraction, nuclear magnetic resonance and mass spectrometry. The synthesized compound displayed “On-Off” fluorescent sensing towards Cu2+ with high selectivity and sensitivity. Fluorescence and UV–vis absorbance spectra studies demonstrated that the proposed sensor can detect Cu2+ directly in acetonitrile solution over a wide range of metal ions including Ag+, Na+, K+, Hg2+, Mg2+, Cd2+, Co2+, Ni2+, Zn2+, Fe2+, Pb2+, Ca2+, Mn2+, Ba2+, Fe3+, Al3+, and Cr3+. Moreover, the synthesized sensor exhibits an instantaneous naked-eye color change from colorless to yellow with the presence of Cu2+ ion. The fluorescence intensity of the sensor has shown a linear response to Cu2+ in the concentration range of 0–15 μM with a detection limit of 2.14 μM. Fluorescence titration, 1H NMR spectrum, ESI–MS, and DFT calculation confirmed that fluorescence quenching is caused by the complex formation between the sensor and Cu2+ with 1:1 stoichiometry.
We also recommend Trading Suppliers and Manufacturers of 2-[4-(BROMOMETHYL)PHENYL]-5-METHYL-1,3,4-OXADIAZOLE (cas 946409-17-2). Pls Click Website Link as below: cas 946409-17-2 suppliers
Prev:Discovery of 2-(4-((1H-1,2,4-triazol-1-yl)methyl)-5-(4-bromophenyl)-1-(2-chlorophenyl)-1H-pyrazol-3-yl)-5-tert-butyl-1,3,4-thiadiazole (GCC2680) as a potent, selective and orally efficacious cannabinoid-1 receptor antagonist
Next:Oxadiazole-based ‘on-off’ fluorescence chemosensor for rapid recognition and detection of Fe2+ and Fe3+ in aqueous solution and in living cells) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Oxadiazole-based ‘on-off’ fluorescence chemosensor for rapid recognition and detection of Fe2+ and Fe3+ in aqueous solution and in living cells07/15/2019
- Discovery of 2-(4-((1H-1,2,4-triazol-1-yl)methyl)-5-(4-bromophenyl)-1-(2-chlorophenyl)-1H-pyrazol-3-yl)-5-tert-butyl-1,3,4-thiadiazole (GCC2680) as a potent, selective and orally efficacious cannabinoid-1 receptor antagonist07/13/2019
- Design, synthesis, and biological evaluation of novel oxadiazole- and thiazole-based histamine H3R ligands07/12/2019
- Synthesis and anticancer evaluation of new lipophilic 1,2,4 and 1,3,4-oxadiazoles07/11/2019


